0001209191-21-005912.txt : 20210128 0001209191-21-005912.hdr.sgml : 20210128 20210128172949 ACCESSION NUMBER: 0001209191-21-005912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210126 FILED AS OF DATE: 20210128 DATE AS OF CHANGE: 20210128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLOWERS KIRSTEN CENTRAL INDEX KEY: 0001797209 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 21566575 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 3033 SCIENCE PARK RD, SUITE 220 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-26 0 0001422143 Kura Oncology, Inc. KURA 0001797209 FLOWERS KIRSTEN C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 Chief Commercial Officer Option to purchase common stock 32.80 2021-01-26 4 A 0 125000 0.00 A 2031-01-25 Common Stock 125000 125000 D This option vests in 48 equal monthly installments commencing on the grant date. James Basta, Attorney-in-fact for Kirsten Flowers 2021-01-28